Levetiracetam 1000 mg Under Non-Fasting Conditions
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the rate and extent of absorption of an
investigational formulation of levetiracetam 1000 mg tablet to an equivalent oral dose of the
commercially available reference product under fed conditions.